See also this year's filing and all EDGAR filings for this company.
PDF Report 0001176309_2022_Oramed_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0001176309, Oramed Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 95,337,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 397,000 |
| 3 | remainder_Assets | 32,265,000 |
| 4 | LiabilitiesCurrent | 6,679,000 |
| 5 | LiabilitiesNoncurrent | 4,803,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,275,495 |
| 9 | ResearchAndDevelopmentExpense | 19,460,223 |
| 10 | remainder_Expenses | 125,839 |
| 11 | remainder_Revenues | 2,143,591 |
| 12 | remainder_NetIncome | 1,078,589 |
| 13 | remainder_ComprehensiveNetIncome | 40,311,290 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 127,999,000 |
| 1 | Liabilities | 11,482,000 |
| 2 | Expenses | 25,861,557 |
| 3 | Revenues | 2,143,591 |
| 4 | StockholdersEquity | 116,517,000 |
| 5 | NetIncome | -22,639,377 |
| 6 | ComprehensiveNetIncome | -2,483,732 |
| 7 | BaseVar | 104,438,014 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.61 |
| 9 | EconomicCapitalRatio | 4.10 |
Edgar->Model Mapping
Feature Distribution
Change over Time
